Isolation of Rat Adipose Tissue Mesenchymal Stem Cells for Differentiation into Insulin-producing Cells
August 29th, 2022
Adipose tissue-derived mesenchymal stem cells (Ad-MSCs) can be a potential source of MSCs that differentiate into insulin-producing cells (IPCs). In this protocol, we provide detailed steps for the isolation and characterization of rat epididymal Ad-MSCs, followed by a simple, short protocol for the generation of IPCs from the same rat Ad-MSCs.
The overall goal of this protocol is to isolate and characterize red adipose tissue, dried mesenchymal stem cells and differentiate them towards insulin-producing cells using simple methods. Mesenchymal stem cells have found the ways in the field of genetics. They can be isolated from various sources such as bone marrow, adipose tissue and perinatal tissue.
They accept excellent cultural characteristics. They are multi potent and can potentially treat various disease. Adipose tissue provides a rich source of mesenchymal stem cells.
These adipose MSCs can be isolated from lipo aspirates easily with high yield compared to other sources like bone marrow. And they can provide a good source for both autologous and allogenic transplantation. In this video are presenting a simple protocol for isolation and characterization of adipose mesenchymal stem cells from rat epididymal fat.
This procedure is a simple highly efficient method for isolation. After isolation, we will endure the differentiation of these adipose mesenchymal stem cells into insulin-producing cells using a simple, relatively short protocol. We will start with isolation of adipose mesenchymal stem cells by collagenous digestion of epididymal fat to obtain stronger vascular fraction.
Then mesenchymal stem cells will be characterized by their plastic adherence, as well as expression of CD markers and differentiation into multiple mesodermal lineages. Anaesthise the animal, then euthanize using cervical dislocation. Spray all over the body with 70%ethanol and start with excision of the skin and the muscles at lower part of the abdomen.
Then expose the testes with the epididymal fat. Gently cut the epididymal fat. Be careful not to cut the blood vessels with the fats.
In a bio safety cabinet, cut the fat tissue into small pieces using forceps and scalpel. Transfer the adipose tissue into centrifuge tube containing 10 milliliters sterile PBS. Start washing by tilting the Falcon tube for 45 seconds.
Then keep the tube standing for five minutes to separate into two layers. Remove the infranated PBS using a 10 milliliter syringe. Repeat this washing steps four to five times till PBS is clear.
After washing, re-suspend adipose tissue in collagenous solution, then incubate in shaking water bath until the tissue is almost homogeneous. Afterwards, vortex the tissue collagenous mixture for 15 seconds, then centrifuge afterwards for five minutes. After centrifugation, you will have three layers.
Carefully discard the supernatant over the stromal vascular fraction. First discard the oil layer at the top carefully, followed by the echos layer without disturbing the stromal vascular fraction pellet. Re-suspend the Stromal vascular fraction in sterile BSA and re-centrifuge for five minutes.
Whole centrifugation, place complete DMEM F-12 media in 25 centimeter square flask. After centrifugation, discard the supernatant and re-suspend the stromal vascular pellet in complete DMEM F-12 media. And transfer to the culture flask.
Place in 37 degree 5%carbon dioxide incubator. Next day, remove unattached cells and replace the media with fresh media. Starting from next day of isolation, The fibroblast-like cells will start to appear.
Then gradually as time passes they will increase in number and size. By passaging, cells will become more homogenous. These cells exhibit all mesenchymal stem cell characterization criteria.
These cells were differentiated towards insulin-producing cells using this simple protocol containing nicotinamide beta mercaptoethanol and Exendin-4. Throughout the differentiation steps, the cells start to lose their fibroblastic shape and I think cluster like morphology. When used insulin-producing cells show positive crimson red disithone staining, then used insulin-producing cells express various beta cell markers like Pdx-1, mafA and insulin.
In addition, induced insulin-producing cells secrete higher levels of insulin in the supernatant when challenged with higher glucose concentration. We provided a detailed, stepwise protocol for isolation and characterization of adipose mesenchymal stem cells. We also provide here a relatively short, simple and efficient protocol for differentiation of adipose mesenchymal stem cells into insulin-producing cells.
This provides a gateway for researcher to enter the field of mesenchymal stem cells and study their differentiation into insulin-producing cells.
View the full transcript and gain access to thousands of scientific videos
Overview
This protocol outlines the isolation and characterization of adipose tissue-derived mesenchymal stem cells (Ad-MSCs) from rat epididymal tissue, followed by their differentiation into insulin-producing cells (IPCs). The methods provided are straightforward and designed for ease of application in a laboratory setting.
Key Study Components
Area of Science
- Stem Cell Biology
- Regenerative Medicine
- Endocrinology
Background
- Mesenchymal stem cells (MSCs) can be derived from various tissues, including adipose tissue.
- Adipose tissue is a rich source of MSCs with favorable culture characteristics.
- MSCs have the potential to differentiate into various cell types, including insulin-producing cells.
- Understanding the differentiation process can aid in developing therapies for diabetes.
Purpose of Study
- To isolate and characterize rat epididymal Ad-MSCs.
- To develop a protocol for differentiating these cells into IPCs.
- To provide a reliable method for future research in regenerative medicine.
Methods Used
- Isolation of adipose tissue-derived MSCs from rat epididymal fat.
- Characterization of isolated MSCs using standard markers.
- Induction of differentiation into insulin-producing cells.
- Assessment of IPC functionality post-differentiation.
Main Results
- Successful isolation of Ad-MSCs with characteristic surface markers.
- Demonstrated differentiation of Ad-MSCs into IPCs.
- Functional assessment showed IPCs capable of insulin secretion.
- Protocol provides a reproducible method for generating IPCs from Ad-MSCs.
Conclusions
- Ad-MSCs are a viable source for generating insulin-producing cells.
- The protocol can facilitate further research into diabetes treatment.
- Future studies may explore the therapeutic potential of these IPCs.
Frequently Asked Questions
Executive Industry Relevance
Adipose-derived mesenchymal stem cells (Ad-MSCs) offer a renewable, ethically non-contentious source for generating insulin-producing cells (IPCs) in diabetes research. The protocol provides a simple, reproducible method for isolating and characterizing Ad-MSCs from rat epididymal fat, followed by differentiation into IPCs using defined biochemical cues. This approach supports target validation and mechanistic de-risking in early-stage therapeutic discovery for metabolic diseases.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of MSC multipotency and lineage commitment toward pancreatic beta-cell fate.
- Operational Value: Provides a standardized source of Ad-MSCs with confirmed CD90, CD73, and CD105 expression for reproducible experimentation.
- Scientific Value: Supports functional validation of IPCs via glucose-stimulated insulin secretion (GSIS) and dithizone staining, confirming beta-cell-like functionality.
Screening & Assay Development
- Scientific Value: Generates IPCs that express key beta-cell transcription factors (Pdx-1, MafA, NKX6.1, Ins1) for use in compound screening assays.
- Operational Value: Enables scalable production of IPCs from Ad-MSCs for high-throughput assessment of insulin secretion dynamics.
- Scientific Value: Facilitates assay standardization through consistent differentiation protocols using HG-DMEM, β-mercaptoethanol, nicotinamide, and exendin-4.
Translational & Preclinical Research
- Scientific Value: Demonstrates translational relevance by producing IPCs that respond to glucose challenges with increased insulin secretion.
- Operational Value: Supports preclinical continuity by providing a renewable cell source for dose-response and efficacy testing in diabetes models.
- Scientific Value: Reduces biological de-risking by confirming multipotency through osteogenic, adipogenic, and chondrogenic differentiation prior to IPC induction.
Pipeline & Workflow Integration
The method integrates into the discovery continuum from early target validation through lead identification to preclinical evaluation, particularly for diabetes therapeutics targeting beta-cell replacement or function.
- Discovery Biology: Supports hypothesis testing on MSC plasticity and lineage specification using defined differentiation cues.
- Screening: Enables assay-ready IPC production with quantifiable outputs such as insulin secretion levels and marker expression.
- Analytics: Provides measurable endpoints including GSIS, dithizone staining, and qPCR for beta-cell markers to compare experimental conditions.
- Translational Research: Connects in vitro IPC generation to preclinical validation through functional insulin release assays.
- Enterprise Reuse: Establishes a reusable platform for generating IPCs from adipose sources across multiple projects and cell lines.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence in IPC generation through multi-lineage characterization and functional validation.
- Operational Value: Standardization and reproducibility of Ad-MSC isolation and differentiation across laboratories.
- Strategic Value: Informs go/no-go decisions in early diabetes therapy development by validating cellular models of beta-cell function.
- Portfolio Impact: Enables risk-adjusted prioritization of stem cell-based approaches for metabolic disease interventions.
Implementation Considerations
- Requires expertise in stem cell culture, differentiation techniques, and flow cytometry for immunophenotyping.
- Necessitates access to centrifuges, biosafety cabinets, incubators, and equipment for glucose-stimulated insulin secretion assays.
- Demands standardization of digestion, washing, and plating procedures to ensure consistent stromal vascular fraction yield.
- Requires adaptation of differentiation timing and reagent concentrations when applying to different adipose depots or species.
- Limited by the need for passage 3-5 cells to ensure homogeneity and multipotency before differentiation induction.
